Low, immune enhancing, dose mtor inhibitors and uses thereof
US10004803B2 · kind B2 · utility
10Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 2016 |
| Grant date | Jun 26, 2018 |
| Priority date | — |
| Expiry date | Oct 12, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to compositions and methods for enhancement of an immune response by partial mTOR inhibition, for example, with low, immune enhancing, doses of an mTOR inhibitor, such as RAD001.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.